Cat.#: ASSD-135
| Description | JC-1 is a Mitochondrial membrane potential indicator/dye that is widely used in apoptosis studies to monitor mitochondrial health. The product is used as an indicator of mitochondrial membrane potential in neurons and also intact tissues and isolated mitochondria, allowing both qualitative visualization and quantitative detection. Interpretation of Results • At low concentrations (due to low mitochondrial membrane potential), JC-1 is predominantly a monomer that yields green fluorescence with emission of 530±15 nm. • At high concentrations (due to high mitochondrial membrane potential), the dye aggregates yielding a red to orange colored emission (590±17.5 nm). Depolarization is indicated by a decrease the aggregate fluorescent count and hyperpolarization is indicated by an increase. |
| Size | 5 mg |
| Chemical Name | 5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide |
| Molecule Weight | 652.2 |
| Molecular formula | C25H27Cl4IN4 |
| Purity | >95% |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg | inquiry |
| ASSD-179 | 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) | 1 mg, 5 mg | inquiry |
| ASSD-145 | Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) | 1 mL | inquiry |
| ASSD-224 | Antifade Fluorescence Mounting Medium with DAPI (aqueous) (AC224) | 10 mL | inquiry |
| ASSD-166 | FURA-2 (AC166) | 1 mg | inquiry |
| ASSD-195 | 6-Aminofluorescein (AC195) | 1 g | inquiry |
| ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
| ASSD-223 | Antifade Fluorescence Mounting Medium (aqueous) (AC223) | 10 mL | inquiry |
| ASSD-225 | Antifade Fluorescence Mounting Medium with Propidium Iodide (aqueous) (AC225) | 10 mL | inquiry |
| ASSD-196 | 5-Carboxyfluorescein (AC196) | 100 mg, 250 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.